A screening strategy for metal antitumor agents as exemplified by gold(III) complexes

Metal-Based Drugs

Volumn 6, Issue 4-5, 1999, Pages 291-300

  Fricker, Simon P ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GOLD COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY TUMOR; TUMOR CELL LINE;

EID: 0032734670     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1999.291     Document Type: Article

References (22)

1. Corbett, T.H.; Valeriote, F.A.; Baker, L.H. Invest. New Drugs 5, 3-20 (1987).
2. Goldin, A.; Schepartz, S.A.; Venditti, J.M.; Devita, V.T. in Methods in Cancer Research Vol XVI; Eds, V.T. Devita Jr., and H. Busch, Academic Press Inc., New York, pp 165-245 (1979).
3. Schwartsmann, G.; Workman, P. Eur. J. Cancer 29A, 3-14 (1993).
4. Boyd, M.R. Principles and Practice of Oncology Update 3, 1-12 (1989).
5. Weinstein, J.N.; Myers, T.G.; O'Connor, P.M.; Friend, S.H.; Fornace, A.J. Jr.; Kohn, K.W.; Fojo, T.; Bates, S.E.; Rubinstein, L.V.; Anderson, N.L.; Buolamwini, J.K.; van Osdol, W.W.; Monks, A.P.; Scudiero, D.A., Sausville, E.A.; Zaharevitz, D.W.; Bunow, B.; Viswanadhan, V.N.; Johnson, G.S.; Wittes, R.E.; Paull, K.D. Science 275 343-349 (1997).
6. Kelland, L.R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P.M.; Valenti, M.; Bryant, A.; Murrer, B.A.; Harrap, K.R. Cancer Res. 53, 2581-2586 (1993).
7. Fricker S.P. in Metal Ions in Biology and Medicine, Eds. Ph. Collery, L.A. Poirier, M. Manfait, J-C. Etienne, John Libbey Eurotext, Paris, pp 452-456 (1990).
8. Powis, G. Curr. Opin. Oncol. 7, 554-559 (1995).
9. Scott, G.K. The Cancer Journal 10, 80-86 (1997).
10. Folkmann, J.; N. Engl. J. Med. 333, 1757-1763 (1995).
11. Ni Dhubhghail, O.M.; Sadler, P.J.; in Metal Complexes in Cancer Chemotherapy, Ed. B.K. Keppler, VCH, Weinheim, pp 221-248 (1993).
12. Shaw, C.F. III, in Metal Compounds in Cancer Therapy, Ed. S.P. Fricker, Chapman and Hall, London, pp 46-64 (1994).
13. Parish, R.V.; Howe, B.P.; Wright, J.P.; Mack, J.; Pritchard, R.G.; Buckley, R.G.; Elsome, A.M.; Fricker, S.P. Inorg. Chem. 35, 1659-1666 (1996).
14. Parish, R.V.; Mack, J.; Hargreaves, L.; Wright, J.P.; Buckley, R.G.; Elsome, A.M.; Fricker, S.P.; Theobald, B.R.C. J. Chem. Soc. Dalton Trans. 69-74 (1996).
15. Fricker, S.P.; Buckley, R.G. Anticancer Res. 16, 3755-3760 (1996).
16. Buckley, R.G.; Elsome, A.M.; Fricker, S.P.; Henderson, G.R.; Theobald, B.R.C.; Parish, R.V.; Howe, B.P.; Kelland, L.R. J. Med. Chem. 39, 5208-5214 (1996).
17. Bruhn, S.L.; Toney, J.H.; Lippard, S.J. in Progress in Inorganic Chemistry: Bioinorganic Chemistry Vol 38, Ed. S.J. Lippard, John Wiley and Sons, Inc., New York, pp 477-516 (1990).
18. Lempers, E.L.M.; Reedijk, J. Adv. Inorg. Chem. 37, 175-217 (1991).
19. Mirabelli, C.K.; Sung, C-M.; Zimmerman, J.P.; Hill, D.T.; Mong, S.; Crooke, ST. Biochem. Pharmacol. 35, 1435-1443 (1986).
20. Kohn, K.W.; Ewig, R.A.G.; Erickson, L.C.; Zwelling, L.A. in DNA Repair- A Laboratory Manual of Research Procedures Vol1 Part B Eds. E.C. Friedberg, P.C. Hanawalt Marcel Dekker, New York, pp 379-401 (1981).
21. Ormerod, M.G.; Orr, R.M.; Peacock, J.H Br. J. Cancer 69, 93-100 (1994).
22. Elsome, A.M. Ph.D. Thesis, King's College, University of London, UK (1995).